BDBM489641 (4-(1-((5-methoxy-7- methyl-1H-indol-4- yl)methyl)-4-methyl- piperidin-2-yl)- phenyl)phosphonic acid::US10961252, Cmp No. 26::US11248000, Cmp No. 26

SMILES COc1cc(C)c2[nH]ccc2c1CN1CCC(C)CC1c1ccc(cc1)P(O)(O)=O

InChI Key InChIKey=MSFLSESDIDKPRG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 489641   

TargetComplement factor B(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489641(US10961252, Cmp No. 26 | (4-(1-((5-methoxy-7- meth...)
Affinity DataIC50: 1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2021
Entry Details
Go to US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489641(US10961252, Cmp No. 26 | (4-(1-((5-methoxy-7- meth...)
Affinity DataIC50: 1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
Go to US Patent